University of Chicago: Rhinitis, Allergic trials

The registry lists 18 Rhinitis, Allergic studies with University of Chicago as lead sponsor. 0 are open to participants now and 13 have results posted.

Phase 2 1Phase 3 2Phase 4 11No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic RhinitisCompletedNCT02402465Phase 4Results posted
• Allergic Rhinitis Changes the Sinus MicrobiomeCompletedNCT01852513Phase 4Results posted
• Effect of Nasaleze on Nasal Challenge With AllergenTerminatedNCT01723397Not applicableResults posted
• NasoNeb Delivery of an Intranasal SteroidCompletedNCT01270256Phase 4Results posted
• Vitamin D Plus Fluticasone PropionateCompletedNCT01103934Phase 4Results posted
• Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy SymptomsCompletedNCT01007253Phase 4Results posted
• Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With AllergenCompletedNCT00791973Phase 4Results posted
• Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)CompletedNCT00791102Phase 2/3Results posted
• Intranasal CO2 for Allergic RhinitisCompletedNCT00618410Not applicableResults posted
• Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?CompletedNCT00618332Not applicableResults posted
• Intranasal Steroids and Oxymetazoline in Allergic RhinitisCompletedNCT00584987Phase 4Results posted
• Treatment of Olfactory Dysfunction in Seasonal Allergic RhinitisTerminatedNCT00361439Phase 4Results posted
• The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic RhinitisTerminatedNCT00119015Phase 4Results posted
• Effects of Allergic Rhinitis on the Nasal/Sinus MicrobiomeCompletedNCT01461200
• Topical Allstate and Nasal Allergen ChallengeWithdrawnNCT01231724Phase 3
• A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal SprayWithdrawnNCT00793858Phase 4
• Intranasal Steroids and the Nasal Ocular ResponseCompletedNCT00473915Phase 4
• Nasal Ocular Reflexes Contribute to Eye SymptomsCompletedNCT00117832Not applicable